Researchers at the University of Pennsylvania (Penn) are developing a new way for cancer-fighting CAR-T cells to overcome the resistance present in some types of B-cell driven cancers.
Although CAR-T treatments have proven effective against numerous cancer types, chronic lymphocytic leukemia (CLL) has so far proven difficult to treat.
But new research from researchers at Penn – who pioneered CAR-T technology – could provide a solution.